KIF15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.281400E-01
Normal-vs-Stage2
3.592000E-01
Normal-vs-Stage3
6.318000E-01
Normal-vs-Stage4
4.274800E-01
Stage1-vs-Stage2
2.487600E-01
Stage1-vs-Stage3
6.825800E-01
Stage1-vs-Stage4
4.964200E-01
Stage2-vs-Stage3
1.729650E-01
Stage2-vs-Stage4
8.804400E-01
Stage3-vs-Stage4
2.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.130000E-01
Normal-vs-AfricanAmerican
7.702200E-01
Normal-vs-Asian
2.289200E-01
Caucasian-vs-AfricanAmerican
3.515000E-01
Caucasian-vs-Asian
9.973200E-01
AfricanAmerican-vs-Asian
1.958240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.155800E-01
Normal-vs-Female
4.325800E-01
Male-vs-Female
7.380600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.974200E-01
Normal-vs-Age(41-60Yrs)
4.417600E-01
Normal-vs-Age(61-80Yrs)
4.062000E-01
Normal-vs-Age(81-100Yrs)
3.509200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.697200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.125400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.897770E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.936200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.574800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.674200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.348400E-01
Normal-vs-Daily Drinker
3.826800E-01
Normal-vs-Weekly Drinker
4.802400E-01
Normal-vs-Occasional Drinker
2.825600E-01
Normal-vs-Social Drinker
4.157600E-01
Non Drinker-vs-Daily Drinker
9.910800E-01
Non Drinker-vs-Weekly Drinker
4.566400E-01
Non Drinker-vs-Occasional Drinker
4.544600E-01
Non Drinker-vs-Social Drinker
6.987600E-01
Daily Drinker-vs-Weekly Drinker
4.504800E-01
Daily Drinker-vs-Occasional Drinker
3.994800E-01
Daily Drinker-vs-Social Drinker
6.664000E-01
Weekly Drinker-vs-Occasional Drinker
7.498800E-01
Weekly Drinker-vs-Social Drinker
6.309000E-01
Occasional Drinker-vs-Social Drinker
7.758600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.738200E-01
Normal-vs-Grade 2
6.324600E-01
Normal-vs-Grade 3
6.524600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.789100E-04
Grade 1-vs-Grade 3
3.215300E-04
Grade 1-vs-Grade 4
5.738200E-01
Grade 2-vs-Grade 3
3.181000E-01
Grade 2-vs-Grade 4
6.324600E-01
Grade 3-vs-Grade 4
6.524600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.473400E-01
Normal-vs-NonDiabetic
4.213800E-01
Diabetic-vs-NonDiabetic
4.395800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.819800E-02
Normal-vs-NoPancreatitis
4.853000E-01
Pancreatitis-vs-NoPancreatitis
2.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.508000E-01
Normal-vs-N1
4.196000E-01
N0-vs-N1
7.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.035800E-02
Normal-vs-TP53-NonMutant
6.017400E-01
TP53-Mutant-vs-TP53-NonMutant
1.25120000005197E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
